PubMedCrossRef 22 Lappin-Scott HM, Costerton JW: Microbial biofi

PubMedCrossRef 22. Lappin-Scott HM, Costerton JW: Microbial biofilms. Cambridge University Press; 1995.CrossRef 23. Allison DG: Community structure and Co-operation in biofilms. Cambridge University Press; 2000.CrossRef 24. Pierce GE: Pseudomonas

aeruginosa, Candida albicans , and device-related nosocomial infections: implications, trends, and potential approaches for control. J Ind Microbiol Biotechnol 2005,32(7):309–318.PubMedCrossRef 25. Senpuku H, Sogame A, Inoshita E, Tsuha Y, Miyazaki H, Hanada N: Systemic diseases in association with microbial species PF 2341066 in oral biofilm from elderly requiring care. Gerontology 2003,49(5):301–309.PubMedCrossRef 26. Hogan DA, Vik A, Kolter R: A Pseudomonas aeruginosa quorum-sensing molecule influences Candida albicans morphology. Mol Microbiol 2004,54(5):1212–1223.PubMedCrossRef 27. El-Azizi MA, Starks SE, Khardori N: Interactions of Candida albicans with other Candida spp . and bacteria in the biofilms. J Appl Microbiol 2004,96(5):1067–1073.PubMedCrossRef 28. Hogan DA, Kolter R:

Pseudomonas-Candida interactions: an ecological role for virulence factors. Science 2002,296(5576):2229–2232.PubMedCrossRef 29. Kaleli I, Cevahir N, Demir M, selleck chemicals Yildirim U, Sahin R: Anticandidal activity of Pseudomonas aeruginosa strains isolated from clinical specimens. Mycoses 2007,50(1):74–78.PubMedCrossRef 30. Grillot R, Portmann-Coffin V, Ambroise-Thomas P: Growth inhibition of pathogenic yeasts by Pseudomonas aeruginosa in-vitro : clinical implications in blood cultures. Mycoses 1994,37(9–10):343–347.PubMed 31. Hockey LJ, Fujita NK, Gibson TR, Rotrosen D, Montgomerie JZ, Edwards JE Jr: Detection of fungemia obscured by concomitant bacteremia: in-vitro and in-vivo studies. J Clin Microbiol 1982,16(6):1080–1085.PubMed 32. Jin Y, Samaranayake

LP, Samaranayake Y, Yip HK: Biofilm formation of Candida albicans is variably affected by saliva and dietary sugars. RAS p21 protein activator 1 Arch Oral Biol 2004,49(10):789–798.PubMedCrossRef 33. Jin Y, Zhang T, Samaranayake YH, Fang HH, Yip HK, Samaranayake LP: The use of new probes and stains for improved assessment of cell viability and extracellular polymeric substances in Candida albicans biofilms. Mycopathologia 2005,159(3):353–360.PubMedCrossRef 34. Ramage G, Vandewalle K, Wickes BL, Lopez-Ribot JL: Characteristics of biofilm formation by Candida albicans . Rev Iberoam Micol 2001,18(4):163–170.PubMed Authors’ contributions LPS, LJJ, RMW and HMHNB conceived this research. HMHNB and JYYY designed and performed the experiments. HMHNB, LPS, LJJ contributed in data analysis and interpretation. HMHNB drafted the manuscript and it was reviewed by LPS, LJJ, RMW and JYYY. All authors read and approved the final manuscript.”
“Background Pseudomonas fluorescens is a highly heterogeneous species, as shown the extensive literature on the taxonomy and phylogeny of this species [1–4]. These studies include saprophytic, rhizopheric and phytopathogenic strains of P.

Comments are closed.